Daiso Agrees to $2.05 Million Civil Penalty In Connection With CPSC’s Allegations That It Imported, Distributed and Sold Toys With Illegal Lead Content
Client Alert | 1 min read | 03.04.10
On March 2, 2010, Daiso Holding USA Inc., Daiso Seattle LLC and Daiso California LLC ("Daiso") reached a consent agreement with the U.S. Consumer Product Safety Commission ("CPSC") filed in the U.S. District Court for the Northern District of California. Daiso allegedly failed to comply with federal laws prohibiting excess levels of lead and phthalates in various toys and children's products. Daiso is also alleged to have failed to meet other federal requirements enforced by the CPSC on children's products. Prior to entering into the current decree, Daiso had received Letters of Advice from the CPSC in connection with violations found during port inspections. Some of these prior violations occurred prior to the enactment of the Consumer Product Safety Improvement Act of 2008 (CPSIA).
Under the CPSIA, it is illegal to import, manufacture, distribute or sell products designed or intended primarily for children 12 and younger containing more than 300 ppm of lead. The CPSIA also prohibits importing, manufacturing, distributing or selling children's toys or child care articles containing more than 0.1% of certain phthalates. Moreover, the CPSIA gave the CPSC additional civil penalty powers.
According to the decree, Daiso will pay a civil penalty of $2.05 million, and is prohibited from importing any children's products into the United States until it meets the other requirements set forth in the consent decree. In addition, Daiso must establish a comprehensive product safety program, including testing, compliance and reporting procedures.
CPSC Chairman Tenenbaum stated that "[t]his landmark agreement for an injunction sets a precedent for any firm attempting to distribute hazardous products to our nation's children.'' She also warned companies against the sale of noncompliant products, stating that, "[w]e are committed to the safety of children's products, and we will use the full force of our enforcement powers to prevent the sale of harmful products."
The size of the penalty and the Chairman's statement are intended to be stern warnings to industry that the CPSC will not hesitate to exercise and take advantage of its increased enforcement powers under the CPSIA. And this action is further evidence of the agency's continued focus on the compliance of children's products with federal safety regulations.
Insights
Client Alert | 4 min read | 03.25.26
NAIC Intensifies AI Regulatory Focus: What Health Insurance Payors Need to Know
The National Association of Insurance Commissioners (NAIC) is intensifying its oversight of how insurers use AI — and the pace of regulatory activity shows no signs of slowing. Over the past several months, the NAIC has published a formal Issue Brief staking out its position on federal AI legislation, launched a multistate AI Evaluation Tool pilot aimed at examining insurers’ AI governance programs, and continued to expand adoption of its AI Model Bulletin across state lines. These developments continue a trend towards enhancing regulation; the NAIC adopted AI Principles in 2020 and a Model Bulletin in 2023 clarifying that existing insurance laws apply to AI systems and establishing expectations for governance, documentation, testing, and third-party oversight. That Model Bulletin has now been adopted in approximately 24 states.
Client Alert | 11 min read | 03.25.26
White House National AI Policy Framework Calls for Preempting State Laws, Protecting Children
Client Alert | 3 min read | 03.24.26
California Considering A Massive Expansion of Its Antitrust Laws
Client Alert | 2 min read | 03.23.26
